PG
IONS icon

PEAK6 Group’s Ionis Pharmaceuticals IONS Stock Holding History

PEAK6 Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$824K Buy
19,786
+10,610
+116% +$470K ﹤0.01% 2134
2018
Q1 		$404K Buy
9,176
+5,527
+151% +$281K ﹤0.01% 2756
2017
Q4 		$184K Buy
+3,649
New +$200K ﹤0.01% 3218
2015
Q4 		– Sell
-6,144
Closed -$332K – 4999
2015
Q3 		$248K Buy
6,144
+3,285
+115% +$170K ﹤0.01% 3548
2015
Q2 		$165K Buy
+2,859
New +$182K ﹤0.01% 3906
2014
Q1 		– Sell
-100
Closed -$4K – 5128
2013
Q4 		$4K Sell
100
-300
-75% -$10.7K ﹤0.01% 4767
2013
Q3 		$8.01K Sell
400
-141,200
-100% -$4.22M ﹤0.01% 4928
2013
Q2 		$3.81K Buy
+141,600
New +$3.01M 0.01% 979

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

PEAK6 Group's IONS Position: Q2 2018 in Review

PEAK6 Group increased its Ionis Pharmaceuticals (IONS) stake by 116% in Q2 2018, buying an estimated $470K and bringing the position to 19,786 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

PEAK6 Group first reported a position in IONS in Q2 2013 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

  • PEAK6 Group held 19,786 shares of Ionis Pharmaceuticals worth $824K as of Q2 2018.
  • PEAK6 Group bought 10,610 Ionis Pharmaceuticals shares in Q2 2018, an estimated $470K.
  • Ionis Pharmaceuticals made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2134 holding.
  • PEAK6 Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
  • 307 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.